Barinthus Biotherapeutics plc (FRA:2AB)
Germany · Delayed Price · Currency is EUR 0.5200
+0.0150 (2.97%)
Last updated: Apr 24, 2026, 8:04 AM CET
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €22.28 million as of April 24, 2026. Its market cap has decreased by -15.47% in one year.
Market Cap
22.28M
Enterprise Value
-28.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.52
Market Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 22.28M, a decrease of -94.42%. That is a compound annual growth rate of -43.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 22.28M | -8.47% |
| Dec 31, 2025 | 24.35M | -48.13% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
| Apr 30, 2021 | 399.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.52M |
| Biomark Diagnostics | 35.52M |
| Paion AG | 545.73K |
| co.don AG | 374.13K |
| bioXXmed AG | 244.68K |
| MagForce AG | 122.29K |